Control of cccDNA function in hepatitis B virus infection

Journal of Hepatology

Volumn 51, Issue 3, 2009, Pages 581-592

  Levrero, Massimo ^a,b   Pollicino, Teresa ^c   Petersen, Jorg ^d   Belloni, Laura ^a   Raimondo, Giovanni ^c   Dandri, Maura ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Andrea Cesalpino Foundation   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Ifi Institute for Interdisciplinary Medicine   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

cccDNA function; Chronic hepatitis B infection; Covalently closed circular DNA; Hepatitis B virus

Indexed keywords

CIRCULAR DNA; VIRUS RNA;

CHRONIC HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL NUCLEUS; MINICHROMOSOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA STABILITY;

ANTIVIRAL AGENTS; DNA, CIRCULAR; DNA, VIRAL; EPIGENESIS, GENETIC; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; VIRUS REPLICATION;

EID: 68049132846     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.05.022     Document Type: Review

References (89)

1. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28 (2006) 112-125
2. Tuttleman J.S., Pourcel C., and Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47 (1986) 451-460
3. Newbold J.E., Xin H., Tencza M., Sherman G., Dean J., Bowden S., et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 69 (1995) 3350-3357
4. Nguyen D.H., Ludgate L., and Hu J. Hepatitis B virus-cell interactions and pathogenesis. Cell Physiol 216 (2008) 289-294
5. Gao W., and Hu J. Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J Virol 81 (2007) 6164-6174
6. Staprans S., Loeb D.D., and Ganem D. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol 65 (1991) 1255-1262
7. Yang W., and Summers J. Illegitimate replication of linear hepadnavirus DNA through non-homologous recombination. J Virol 69 (1995) 4029-4036
8. Mason W.S., Aldrich C., Summers J., and Taylor J.M. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc Natl Acad Sci USA 79 (1982) 3997-4001
9. Wu T.T., Coates L., Aldrich C.E., Summers J., and Mason W.S. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175 (1990) 255-261
10. Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 42 (2005) 302-308
11. Dandri M., Burda M.R., Will H., and Petersen J. Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. Hepatology 32 (2000) 139-146
12. Moraleda G., Saputelli J., Aldrich C.E., Averett D., Condreay L., and Mason W.S. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 71 (1997) 9392-9399
13. Wong D.K., Yuen M.F., Yuan H., Sum S.S., Hui C.K., Hall J., et al. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 40 (2004) 727-737
14. Zhang Y.Y., Zhang B.H., Theele D., Litwin S., Toll E., and Summers J. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci USA 100 (2003) 12372-12377
15. Summers J., Smith P.M., and Horwich A.L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64 (1990) 2819-2824
16. Lenhoff R.J., and Summers J. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol 68 (1994) 4565-4571
17. Mason W.S., Litwin S., Xu C., and Jilbert A.R. Hepatocyte turnover in transient and chronic hepadnavirus infections. J Viral Hepat 14 (2007) 22-28
18. Summers J., Jilbert A.R., Yang W., Aldrich C.E., Saputelli J., Litwin S., et al. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci USA 100 (2003) 11652-11659
19. Mason W.S., Xu C., Low H.C., Saputelli J., Aldrich C.E., Scougall C., et al. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J Virol 83 (2009) 1778-1789
20. Summers J., and Mason W.S. Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc Natl Acad Sci USA 101 (2004) 638-640
21. Mason W.S., Jilbert A.R., and Summers J. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc Natl Acad Sci USA 102 (2005) 1139-1144
22. Penna A., Artini M., Cavalli A., Levrero M., Bertoletti A., Pilli M., et al. Longlasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 98 (1996) 1185-1194
23. Rehermann B., Ferrari C., Pasquinelli C., and Chisari F.V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2 (1996) 1104-1108
24. Zoulim F. Assessment of treatment efficacy in HBV infection and disease. J Hepatol 44 (2006) S95-S99
25. Kock J., Baumert T.F., Delaney W., Blum H.E., and von Weizsacker F. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 38 (2003) 1410-1418
26. Delmas J., Schorr O., Jamard C., Gibbs C., Trepo C., Hantz O., et al. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro. Antimicrob Agents Chemother 46 (2002) 425-433
27. Le Guerhier F., Pichoud C., Guerret S., Chevallier M., Jamard C., Hantz O., et al. Characterization of the antiviral effect of 2′,3′-dideoxy-2′, 3′-didehydro-beta-Lfluorocytidine in the duck hepatitis B virus infection model. Antimicrob Agents Chemother 44 (2000) 111-122
28. Sung J.J., Wong M.L., Bowden S., Liew C.T., Hui A.Y., Wong V.W., et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 128 (2005) 1890-1897
29. Wursthorn K., Lutgehetmann M., Dandri M., Volz T., Buggisch P., Zollner B., et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44 (2006) 675-684
30. Lutgehetmann M., Volzt T., Quaas A., Zankel M., Fischer C., Dandri M., et al. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication. Antivir Ther 13 (2008) 57-66
31. Petersen J., Dandri M., Mier W., Lütgehetmann M., Volz T., von Weizsäcker F., et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nature Biotech 26 (2008) 335-341
32. Bock C.T., Schranz P., Schroder C.H., and Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 8 (1994) 215-229
33. Prieto-Soto A., Gourlie B., Miwa M., Pigiet V., Sugimura T., Malik N., et al. Polyoma virus minichromosomes: poly ADP-ribosylation of associated chromatin proteins. J Virol 45 (1983) 600-606
34. Griffith J.D. Chromatin structure: deduced from a minichromosome. Science 187 (1975) 1202-1203
35. Favre M., Breitburd F., Croissant O., and Orth G. Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses. J Virol 21 (1977) 1205-1209
36. Rosl F., Waldeck W., Zentgraf H., and Sauer G. Properties of intracellular bovine papillomavirus chromatin. J Virol 58 (1986) 500-507
37. Tate V.E., and Philipson L. Parental adenovirus DNA accumulates in nucleosome-like structures in infected cells. Nucleic Acids Res 6 (1979) 2769-2785
38. Shaw J.E., Levinger L.F., and Carter Jr. C.W. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J Virol 29 (1979) 657-665
39. Deshmane S.L., and Fraser N.W. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 63 (1989) 943-947
40. Bock C.T., Schwinn S., Locarnini S., Fyfe J., Manns M.P., Trautwein C., et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol 307 (2001) 183-196
41. Moolla N., Kew M., and Arbuthnot P. Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9 (2002) 323-331
42. Orlando V. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked chromatin immunoprecipitation. Trends Biochem Sci 25 (2000) 99-104
43. Kuo M.H., and Allis C.D. In vivo cross-linking and immunoprecipitation for studying dynamic protein: DNA associations in a chromatin environment. Methods 19 (1999) 425-433
44. Pollicino T., Belloni L., Raffa G., Pediconi N., Squadrito G., Raimondo G., et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130 (2006) 823-837
45. Werle-Lapostolle B., Bowden S., Locarnini S., Wursthorn K., Petersen J., Lau G., et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126 (2004) 1750-1758
46. Gunther S., Li B.C., Miska S., Kruger D.H., Meisel H., and Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69 (1995) 5437-5444
47. Lucifora J., Durantel D., Belloni L., Barraud L., Villet S., Vincent I.E., et al. Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector. J Gen Virol 89 (2008) 1819-1828
48. Cougot D, Wu Y, Buendia MA, Neuveut C. Role of HBx and its cellular partners in the regulation of viral transcription. In: 2007 international meeting the molecular biology of hepatitis B viruses, Rome, Italy, September 16-20, 2007.
49. Belloni L., Pollicino T., Cimino L., Raffa G., Raimondo G., and Levrero M. HBX binds in vivo on the HBV minichromosome, modifies the epigenetic regulation of ccc-DNA function and potentiates HBV replication. J Hepatol 48 (2008) S25
50. Laras A., Koskinas J., Dimou E., Kostamena A., and Hadziyannis S.J. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 44 (2006) 694-702
51. Volz T., Lutgehetmann M., Wachtler P., Jacob A., Quaas A., Murray J.M., et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133 (2007) 843-852
52. Dandri M., Lutgehetmann M., Volz T., and Petersen J. Small animal model systems for studying hepatitis B virus replication and pathogenesis. Semin Liver Dis 26 (2006) 181-191
53. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., and Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
54. Boni C., Fisicaro P., Valdatta C., Amadei B., Di Vincenzo P., Giuberti T., et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81 (2007) 4215-4225
55. Puro R., and Schneider R.J. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol 81 (2007) 7351-7362
56. Visvanathan K., Skinner N.A., Thompson A.J., Riordan S.M., Sozzi V., Edwards R., et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45 (2007) 102-110
57. Schwabe R.F., and Brenner D.A. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290 (2006) G583-G589
58. Wu J., Lu M., Meng Z., Trippler M., Broering R., Szczeponek A., et al. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46 (2007) 1769-1778
59. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40 (2004) 738-746
60. Chen W., Zhang Z., Shi M., Chen L., Fu J., Shi F., et al. Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response. Clin Immunol 129 (2008) 295-303
61. Lim S.G., Cheng Y., Guindon S., Seet B.L., Lee L.Y., Hu P., et al. Viral quasi-species evolution during hepatitis Be antigen seroconversion. Gastroenterology 133 (2007) 951-958
62. Gunther S., Sommer G., Von Breunig F., Iwanska A., Kalinina T., Sterneck M., et al. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 36 (1998) 531-538
63. Parekh S., Zoulim F., Ahn S.H., Tsai A., Li J., Kawai S., et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77 (2003) 6601-6612
64. Jammeh S., Tavner F., Watson R., Thomas H.C., and Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 89 (2008) 901-909
65. Koepke A., Volz T., Lutgehetmann M., Lohse A.W., Dandri M., and Petersen J. Genetic variability of the cccDNA regulatory region changes significantly in the different phases of chronic HBV infection. Hepatology 48 (2008) 683A
66. Sterner D.E., and Berger S.L. Acetylation of histones and transcription related factors. Microbiol Mol Biol Rev 64 (2000) 435-459
67. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
68. Turner B.M. Cellular memory and the histone code. Cell 111 (2002) 285-291
69. Klass C.M., Krug L.T., Pozharskaya V.P., and Offermann M.K. The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105 (2005) 4028-4034
70. Belloni L., Testoni B., Scisciani C., Pollicino T., Raimondo G., and Levrero M. Modulation of the epigenetic regulation of the cccDNA function contributes to IFNα inhibition of HBV replication. J Hepatol 50 (2009) S32
71. Guidotti L.G., Borrow P., Brown A., McClary H., Koch R., and Chisari F.V. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 189 (1999) 1555-1564
72. Rang A., Gunther S., and Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J Hepatol 31 (1999) 791-799
73. Keasler V.V., Hodgson A.J., Madden C.R., and Slagle B.L. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 81 (2007) 2656-2662
74. Vivekanandan P., Thomas D., and Torbenson M. Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat 15 (2008) 103-107
75. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49 (2008) 652-657
76. Brechot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., and Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely occult?. Hepatology 34 (2001) 194-203
77. Hu K.Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9 (2002) 243-257
78. Torbenson M., and Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2 (2002) 479-486
79. Raimondo G., Pollicino T., Cacciola I., and Squadrito G. Occult hepatitis B virus infection. J Hepatol 46 (2007) 160-170
80. Chaudhuri V., Tayal R., Nayak B., Acharya S.K., and Panda S.K. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127 (2004) 1356-1371
81. Pollicino T., Raffa G., Costantino L., Lisa A., Campello C., Squadrito G., et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45 (2007) 277-285
82. Vivekanandan P., Kannangai R., Ray S.C., Thomas D.L., and Torbenson M. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis 46 (2008) 1227-1236
83. Mason A.L., Xu L., Guo L., Kuhns M., and Perrillo R.P. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 27 (1998) 1736-1742
84. Marusawa H., Uemoto S., Hijikata M., Ueda Y., Tanaka K., Shimotohno K., et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31 (2000) 488-495
85. Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Craxi A., et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126 (2004) 102-110
86. Zerbini A., Pilli M., Boni C., Fisicaro P., Penna A., Di Vincenzo P., et al. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 134 (2008) 1470-1481
87. Lalazar G., Rund D., and Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 136 (2007) 699-712
88. Marzano A., Angelucci E., Andreone P., Brunetto M., Bruno R., Burra P., et al. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 39 (2007) 397-408
89. Zimmerman K.A., Fischer K.P., Joyce M.A., and Tyrrell D.L. Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture. J Virol 82 (2008) 8013-8021